PATENT CLAIM ANALYSIS

Application Number: 15947820
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "190100"]

Abstract:
This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including  Escherichia coli  and multi-drug resistant  E. coli . This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including  E. coli  and multi-drug resistant  E. coli.

Claim (Index 55):
A method for preparing a vaccine comprising the steps of: providing an adjuvant formulation comprising an effective amount of phosphorylated hexaacyl disaccharide or pharmaceutically acceptable salts thereof, wherein the adjuvant formulation has stability of 60 or more days at room temperature; and combining the adjuvant formulation with an effective amount of antigen.

Metadata:
- Claim Count in Document: 98.0
- Percentile: 91.0
- Lexical Diversity: 1.96
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15727615', '14660523', '14663690', '15130720', '15295287']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.828795077170223
- 35 USC 102 Novelty (BERT): 0.6212576246916318
- Combined Prediction Score: 0.808041331922364
- Mean Citation Score: 598.0033559999998
- Max Citation Score: 620.15393
- Similarity Product: 522.6041262544411

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test